SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending as investors digest a massive revenue beat alongside high-profile contract wins, with the community actively debating whether the stock's recent volatility is a short-term reaction to broader market pressure or a long-term entry opportunity. Discussion is focused on the tension between robust AI infrastructure demand and concerns over debt levels, with many traders looking toward upcoming earnings calls for further clarity on hyperscaler partnerships.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending due to intense community speculation regarding potential platform growth, executive news, and heavy partisan debate surrounding Donald Trump's political narrative. Investors and community members are actively discussing the stock's volatility, potential catalysts like upcoming merger filings, and a highly polarized discourse over the company's valuation versus its revenue.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is facing extreme volatility after FDA briefing documents cast doubt on the company's statistical analysis plan (SAP), leading to community debate over whether the agency's assessment is based on obsolete data or legitimate efficacy concerns. While some investors fear a potential complete response letter, others are doubling down, arguing the market is overreacting to bureaucratic errors and pointing toward the upcoming advisory committee meeting as a binary event that will ultimately clarify the path forward.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as investors weigh an ongoing patent infringement lawsuit against the company's strategic pivot toward AI infrastructure and power semiconductors. Community sentiment is deeply divided, with many traders focused on the stock's recent volatility and the potential impact of future guidance on its long-term growth prospects.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is surging following a massive earnings beat and an upgraded FY27 outlook, with the company forecasting accelerated revenue growth that significantly exceeds analyst expectations. The community is buzzing over the stock's impressive operating margin expansion and its strategic role in the AI infrastructure supply chain, fueling debates among investors over whether to lock in gains after the recent rally or continue holding to capture long-term growth as hyperscalers maintain high capital expenditure levels.

Amkor Technology, Inc. engages in the provision of outsourced semiconductor packaging and test services. Its services include design, package characterization, test, and wafer bumping services. The company was founded in 1968 and is headquartered in Tempe, AZ.

AMKOR Technology Inc.

Amkor Technology is trending as investors weigh a strong quarterly performance and improved margins against a cautious third-quarter revenue outlook. While the community remains divided over the short-term price action, there is significant ongoing discussion regarding the stock's long-term potential as a critical player in the advanced semiconductor packaging and AI supply chain.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors react to a significant $1.5 million NSF grant for fault-tolerant computing and a strategic pivot toward commercial enterprise partnerships like the expanded AT&T agreement. Community discussion remains polarized, with bulls highlighting the stock's potential as a sector leader following its Nasdaq transition, while bears caution against high valuation multiples and the volatility common in high-beta speculative tech.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BitMine Immersion Technologies is currently in the spotlight as investors debate the impact of the company's aggressive share buyback program and its ongoing treasury strategy focused on Ethereum accumulation. While some in the community see the recent buybacks as a key catalyst for potential price recovery and a way to counter share dilution, others remain skeptical, pointing to the persistent discount between the stock's market value and its underlying crypto holdings as a sign of management's poor execution.

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for brain disorders. It develops the ML-007-MA product for treatment of schizophrenia and ADP. Its platforms include Optogenetics, Transcriptnomics, and STARmap. The company was founded by Christopher A. Kroeger, Karl Deisseroth, Robert Malenka, and Karoly Nikolich in November 2018 and is headquartered in Redwood City, CA.

MapLight Therapeutics Inc.

MapLight Therapeutics is seeing intense volatility following mixed topline results from its Phase 2 ZEPHYR trial, with community sentiment deeply divided between bargain hunters seeking a rebound and critics questioning the clinical data. While some traders are focused on the company's cash position and potential for a 'snap back,' others are wary of the sharp share price decline and are debating whether the recent dip represents an overreaction or a long-term valuation shift.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is facing significant downward pressure as investors grow anxious over reports of circular financing related to OpenAI infrastructure investments and broader semiconductor sector concerns. Despite the volatility, community sentiment remains deeply divided between those viewing the decline as a fear-driven buying opportunity and others warning that the company's aggressive debt-backed expansion strategies signal a potential bubble.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should You Buy, Sell or Hold FormFactor Stock Before Q2 Earnings?

FORM heads into Q2 earnings with AI, HBM and advanced packaging momentum, but valuation and trade risks temper the upside.


Should You Buy, Sell, or Hold TER Stock Before Q2 Earnings Release?

Teradyne's Q2 earnings are likely to benefit from AI-driven demand, robotics momentum and new products supporting growth as investors weigh its premium valuation.


KLA's Q4 Earnings Loom: Buy, Sell or Hold the KLAC Stock?

KLAC heads into fiscal Q4 earnings with AI-driven demand and advanced packaging growth, while higher DRAM costs pressure margins.


LRCX Poised for a Q4 Earnings Surprise: Should You Buy the Stock Now?

Lam Research's Q4 results are expected to reflect the benefits of strong demand for AI chips and rising DRAM spending.

AMSL, AMAT, KLAC, LRCX: Chipmaking Equipment Stocks Rise On Intel’s CapEx Bump

Equity

ASML Holding, Lam Research, KLA Corp and Applied Materials are among the world’s top suppliers of semiconductor manufacturing equipment.


ASML Holdings' EUV Leadership Strengthens Long-Term Growth

ASML's EUV dominance and next-gen High-NA systems position it to benefit as AI demand drives advanced chip production.

Unveiling KLA (KLAC) Q4 Outlook: Wall Street Estimates for Key Metrics

Besides Wall Street's top-and-bottom-line estimates for KLA (KLAC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.

KLA (KLAC) Suffers a Larger Drop Than the General Market: Key Insights

In the latest trading session, KLA (KLAC) closed at $214.69, marking a -1.32% move from the previous day.

KLA (KLAC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

KLA (KLAC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ARM, QCOM, KLAC Stocks Rise Despite Price Target Cuts By UBS Amid Chip Stocks’ Pullback

ARM’s stock saw the largest price target cut, though UBS reiterated its 'Buy' rating and retained 'Neutral' ratings for both Qualcomm and KLA.


KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

KLA Corp.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

The Fed's July 28-29 meeting has markets debating a hold versus a hike, not a cut, with CME FedWatch pricing roughly a 65% chance of no change and rising odds of a September rate increase amid inflation running well above the 2% target. What do you expect the Fed to decide? Drop a comment with when you expect the first cut/hike to be.

What do you expect the Fed to decide at its FOMC meeting?  
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

KLACKLA Corp.

Latest KLAC News